rhenium-186 hedp has been researched along with Pain in 30 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (6.67) | 18.2507 |
| 2000's | 20 (66.67) | 29.6817 |
| 2010's | 8 (26.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Banerjee, S; Dash, A; Kameswaran, M; Kumar, C; Mallia, MB; Sarma, HD; Sharma, R | 1 |
| Amoui, M; Asli, IN; Assadi, M; Kalantari, BA; Mirzaee, HR; Pirayesh, E; Rakhsha, A; Shafiei, B; Tabei, F | 1 |
| Beekman, FJ; Bloemendal, HJ; Breukels, OB; de Graaf, H; de Klerk, JM; Hendrikse, NH; Lange, R; Malingré, MM; Rummenie, RG; ter Heine, R; van den Berg, L; van der Westerlaken, MM; Wakker, AM; Wielders, JP | 1 |
| Aswathy, KK; Banerjee, S; Kalarikal, R; Kamaleshwaran, KK; Kameswaran, M; Mallia, MB; Shinto, AS | 1 |
| Baziotis, N; Limouris, GS; Zafeirakis, A; Zissimopoulos, A | 2 |
| Chen, S; Cheng, A; Dong, M; Yin, D; Zhang, Y | 1 |
| Alsharif, A; Boni, G; Borsò, E; Chiacchio, S; Greco, C; Grosso, M; Lorenzoni, A; Manca, G; Mariani, G; Mazzarri, S; Nyakale, N; Volterrani, D | 1 |
| Aras, G; Gümüş-Akay, G; Ibiş, E; Köroğlu, R; Küçük, O; Ozkal-Baydin, P; Rüstemoğlu, A; Sunguroğlu, A; Varol, N; Yüksel, S | 1 |
| Kotzerke, J; Kropp, J; Liepe, K; Runge, R | 1 |
| Bandurski, T; Derejko, M; Romanowicz, G; Scheffler, J | 1 |
| Endo, K; Li, S; Liu, J; Tanada, S; Tian, M; Zhang, H | 1 |
| de Klerk, JM; Lam, MG; van Rijk, PP | 1 |
| Kotzerke, J; Liepe, K; Runge, R | 1 |
| Anagnostopoulou, US; Datseris, EI; Leondi, AH; Leontopoulou, SA; Papadaki, EK; Rapti, AS; Souvatzoglou, MA; Zerva, CJ | 1 |
| Chen, SX; DU, JQ; Jiang, NY; Liang, JG; Liu, XG; Lu, XP | 1 |
| Bergomi, S; Maini, CL; Romano, L; Sciuto, R | 1 |
| Antonini, N; Hoefnagel, CA; Horenblas, S; Valdes Olmos, RA; van der Poel, HG | 1 |
| Benassi, M; D'Andrea, M; Maini, CL; Pasqualoni, R; Sciuto, R; Strigari, L | 1 |
| Kotzerke, J; Liepe, K | 1 |
| de Klerk, JM; Lam, MG; van Rijk, PP; Zonnenberg, BA | 1 |
| Bender, H; Biersack, HJ; Dierke-Dzierzon, C; Grünwald, F; Mallmann, P; Palmedo, H; Reichmann, K; Schomburg, A; Schöneich, G; Zamorra, P | 1 |
| Holle, LH; Humke, U; Kirsch, CM; Oberhausen, E; Trampert, L; Ziegler, M | 1 |
| Aras, G; Baltaci, S; Bedük, Y; Canakci, N; Ibiş, E; Küçük, NO; Ozalp, G; Soylu, A | 1 |
| Franke, WG; Hliscs, R; Koch, R; Kropp, J; Liepe, K; Runge, R | 1 |
| Franke, WG; Hliscs, R; Kropp, J; Liepe, K | 1 |
| Bestagno, M; Cittanti, C; Colamussi, P; Dafermou, A; Giganti, M; Piffanelli, A | 1 |
| Banerjee, S; Chaudhari, PR; Kothari, K; Pillai, MR; Samuel, G; Sarma, HD; Unni, PR; Unnikrishnan, TP | 1 |
| Bangard, M; Biersack, HJ; Menzel, C; Palmedo, H; Risse, J; Rockstroh, JK; Schliefer, K | 1 |
| Li, S; Liu, J; Tian, M; Wang, J; Zhang, H; Zheng, X | 1 |
5 review(s) available for rhenium-186 hedp and Pain
| Article | Year |
|---|---|
Radionuclide therapy and integrated protocols for bone metastases.
Topics: Bone Neoplasms; Combined Modality Therapy; Diphosphonates; Drug Therapy, Combination; Etidronic Acid; Humans; Organometallic Compounds; Organophosphorus Compounds; Pain; Palliative Care; Patient Selection; Radioimmunotherapy; Radiopharmaceuticals; Technetium Tc 99m Medronate; Treatment Outcome | 2011 |
Application of rhenium-188 HEDP in bone metastases therapy.
Topics: Bone Neoplasms; Etidronic Acid; Humans; Leukopenia; Organometallic Compounds; Pain; Palliative Care; Practice Patterns, Physicians'; Radiopharmaceuticals; Rhenium; Thrombocytopenia; Treatment Outcome | 2003 |
186Re-HEDP for metastatic bone pain in breast cancer patients.
Topics: Bone Neoplasms; Breast Neoplasms; Dose-Response Relationship, Radiation; Etidronic Acid; Female; Humans; Maximum Tolerated Dose; Organometallic Compounds; Pain; Palliative Care; Radiation Injuries; Radioimmunotherapy; Radiopharmaceuticals; Radiotherapy Dosage; Rhenium; Treatment Outcome | 2004 |
Radionuclide therapy with bone seeking radionuclides in palliation of painful bone metastases.
Topics: Bone Neoplasms; Etidronic Acid; Humans; Organometallic Compounds; Organophosphorus Compounds; Pain; Palliative Care; Radionuclide Imaging; Strontium | 2003 |
Bone seeking radiopharmaceuticals for palliation of pain in cancer patients with osseous metastases.
Topics: Bone Neoplasms; Clinical Trials as Topic; Etidronic Acid; Humans; Medical Oncology; Models, Chemical; Neoplasm Metastasis; Neoplasms; Organometallic Compounds; Organophosphorus Compounds; Pain; Radiometry; Radionuclide Imaging; Radiopharmaceuticals; Strontium; Treatment Outcome | 2007 |
10 trial(s) available for rhenium-186 hedp and Pain
| Article | Year |
|---|---|
Phase 2 study of a high dose of 186Re-HEDP for bone pain palliation in patients with widespread skeletal metastases.
Topics: Adult; Aged; Bone Neoplasms; Etidronic Acid; Female; Humans; Male; Middle Aged; Organometallic Compounds; Pain; Pain Management; Palliative Care; Radiation Dosage | 2013 |
The tolerance and therapeutic efficacy of rhenium-188 hydroxyethylidene diphosphonate in advanced cancer patients with painful osseous metastases.
Topics: Blood Cell Count; Bone Neoplasms; Electrocardiography; Etidronic Acid; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasms; Organometallic Compounds; Pain; Pain Measurement; Palliative Care | 2011 |
Therapeutic efficiency of rhenium-188-HEDP in human prostate cancer skeletal metastases.
Topics: Aged; Aged, 80 and over; Blood Cell Count; Bone Neoplasms; Etidronic Acid; Humans; Male; Middle Aged; Neoplasm Staging; Organometallic Compounds; Pain; Pain Measurement; Prostatic Neoplasms; Radioisotopes; Radionuclide Imaging; Rhenium; Treatment Outcome | 2003 |
The benefit of bone-seeking radiopharmaceuticals in the treatment of metastatic bone pain.
Topics: Aged; Aged, 80 and over; Analgesics, Non-Narcotic; Bone Neoplasms; Breast Neoplasms; Etidronic Acid; Female; Humans; Karnofsky Performance Status; Male; Middle Aged; Organometallic Compounds; Organophosphorus Compounds; Pain; Palliative Care; Prostatic Neoplasms; Radioisotopes; Surveys and Questionnaires; Time Factors; Treatment Outcome | 2005 |
Palliative treatment of painful disseminated bone metastases with 186Rhenium-HEDP in patients with lung cancer.
Topics: Bone Neoplasms; Carcinoma; Etidronic Acid; Female; Humans; Lung Neoplasms; Male; Middle Aged; Organometallic Compounds; Pain; Palliative Care; Patient Selection; Radiopharmaceuticals; Treatment Outcome | 2004 |
[Clinical value of combined therapy with 188Re-HEDP and pamidronate in breast cancer with bone metastasis].
Topics: Adult; Aged; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Carcinoembryonic Antigen; Combined Modality Therapy; Diphosphonates; Etidronic Acid; Female; Follow-Up Studies; Humans; Middle Aged; Organometallic Compounds; Pain; Pain Management; Pamidronate; Radioisotopes; Rhenium | 2005 |
A comparative study of 188Re-HEDP, 186Re-HEDP, 153Sm-EDTMP and 89Sr in the treatment of painful skeletal metastases.
Topics: Aged; Aged, 80 and over; Analgesics, Non-Narcotic; Bone Marrow; Bone Neoplasms; Breast Neoplasms; Etidronic Acid; Female; Humans; Male; Middle Aged; Organometallic Compounds; Organophosphorus Compounds; Pain; Prospective Studies; Prostatic Neoplasms; Quality of Life; Radiopharmaceuticals; Strontium; Treatment Outcome | 2007 |
[Pain therapy with rhenium-186 HEDP in multiple bone metastases].
Topics: Bone Neoplasms; Breast Neoplasms; Diphosphonates; Etidronic Acid; Female; Humans; Male; Neoplasm Metastasis; Organometallic Compounds; Organotechnetium Compounds; Pain; Palliative Care; Prostatic Neoplasms; Radioisotopes; Rhenium; Time Factors; Tomography, Emission-Computed | 1996 |
[Comparison of rhenium-188, rhenium-186-HEDP and strontium-89 in palliation of painful bone metastases].
Topics: Bone Neoplasms; Breast Neoplasms; Etidronic Acid; Female; Humans; Leukocyte Count; Male; Middle Aged; Organometallic Compounds; Pain; Palliative Care; Platelet Count; Prostatic Neoplasms; Radioisotopes; Rhenium; Strontium Radioisotopes; Tomography, X-Ray Computed | 2000 |
Painful multifocal arthritis: therapy with rhenium 186 hydroxyethylidenediphosphonate ((186)Re HEDP) after failed treatment with medication--initial results of a prospective study.
Topics: Arthritis, Rheumatoid; Etidronic Acid; Female; Humans; Male; Middle Aged; Organometallic Compounds; Pain; Pain Management; Prospective Studies; Radioisotopes; Rhenium; Treatment Failure | 2001 |
15 other study(ies) available for rhenium-186 hedp and Pain
| Article | Year |
|---|---|
In Vitro Evaluation of
Topics: Bone Neoplasms; Cell Culture Techniques; Etidronic Acid; Female; Humans; Male; Organometallic Compounds; Pain; Radiopharmaceuticals | 2017 |
Bench to bedside development of GMP grade Rhenium-188-HEDP, a radiopharmaceutical for targeted treatment of painful bone metastases.
Topics: Animals; Bone Neoplasms; Etidronic Acid; Feasibility Studies; Humans; Male; Mice; Organometallic Compounds; Pain; Prostatic Neoplasms; Quality Control; Radionuclide Imaging; Radiopharmaceuticals; Tissue Distribution; Translational Research, Biomedical | 2014 |
A Freeze-Dried Kit for the Preparation of (188)Re-HEDP for Bone Pain Palliation: Preparation and Preliminary Clinical Evaluation.
Topics: Bone Neoplasms; Etidronic Acid; Freeze Drying; Humans; Organometallic Compounds; Pain; Palliative Care; Radiopharmaceuticals; Reagent Kits, Diagnostic | 2016 |
Management of metastatic bone pain with repeated doses of rhenium 186-HEDP in patients under therapy with zoledronic acid: a safe and additively effective practice.
Topics: Adult; Aged; Aged, 80 and over; Analgesics; Bone Neoplasms; Breast Neoplasms; Diphosphonates; Etidronic Acid; Female; Humans; Imidazoles; Male; Middle Aged; Neoplasm Metastasis; Organometallic Compounds; Pain; Pain Measurement; Prostatic Neoplasms; Treatment Outcome; Zoledronic Acid | 2009 |
Introduction of a new semi-quantitative index with predictive implications in patients with painful osseous metastases after (186)Re-HEDP therapy.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Breast Neoplasms; Etidronic Acid; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Organometallic Compounds; Pain; Pain Measurement; Predictive Value of Tests; Prostatic Neoplasms; Radioisotopes; Radiopharmaceuticals; Rhenium | 2011 |
Potential genotoxic effect of 186Re-HEDP on human lymphocyte cells: in-vitro evaluation with micronucleus-FISH analysis.
Topics: Adult; Bone Neoplasms; Etidronic Acid; Female; Humans; In Situ Hybridization, Fluorescence; Lymphocytes; Male; Middle Aged; Organometallic Compounds; Pain; Radioisotopes; Young Adult | 2012 |
Rhenium-188-HEDP therapy for the palliation of pain due to osseous metastases in lung cancer patients.
Topics: Adult; Aged; Bone Neoplasms; Dose-Response Relationship, Radiation; Etidronic Acid; Female; Follow-Up Studies; Humans; Leukocyte Count; Lung Neoplasms; Male; Middle Aged; Organometallic Compounds; Pain; Palliative Care; Radionuclide Imaging; Rhenium | 2003 |
Serum hemoglobin levels predict response to strontium-89 and rhenium-186-HEDP radionuclide treatment for painful osseous metastases in prostate cancer.
Topics: Aged; Bone Neoplasms; Etidronic Acid; Hemoglobins; Humans; Male; Organometallic Compounds; Pain; Predictive Value of Tests; Prostatic Neoplasms; Radioisotopes; Retrospective Studies; Strontium Radioisotopes | 2006 |
Radiopharmaceutical therapy of bone metastases with 89SrCl2, 186Re-HEDP and 153Sm-EDTMP: a dosimetric study using Monte Carlo simulation.
Topics: Bone Neoplasms; Computer Simulation; Etidronic Acid; Humans; Models, Biological; Monte Carlo Method; Organometallic Compounds; Organophosphorus Compounds; Pain; Palliative Care; Radiometry; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Strontium; Treatment Outcome | 2007 |
[Palliative treatment for pain in osseous metastasized prostatic carcinoma with osteotropic rhenium-186 hydroxyethylidene diphosphonate (HEDP)].
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Diphosphonates; Etidronic Acid; Humans; Male; Middle Aged; Organometallic Compounds; Organotechnetium Compounds; Pain; Palliative Care; Prostatic Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Radiotherapy; Rhenium | 1997 |
Palliative analgesic effect of Re-186 HEDP in various cancer patients with bone metastases.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Breast Neoplasms; Etidronic Acid; Female; Humans; Lung Neoplasms; Male; Middle Aged; Nasopharyngeal Neoplasms; Organometallic Compounds; Pain; Palliative Care; Prostatic Neoplasms; Radiopharmaceuticals; Rectal Neoplasms; Rhenium | 2000 |
Significant reduction of the mass of bone metastasis 1 year after rhenium-186 HEDP pain palliation therapy.
Topics: Bone Neoplasms; Etidronic Acid; Humans; Male; Middle Aged; Organometallic Compounds; Pain; Palliative Care; Prostatic Neoplasms; Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Rhenium; Technetium Tc 99m Medronate | 2000 |
A multicentre observational study of radionuclide therapy in patients with painful bone metastases of prostate cancer.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Etidronic Acid; Humans; Injections, Intravenous; Male; Middle Aged; Organometallic Compounds; Pain; Pain Measurement; Palliative Care; Prostatic Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Rhenium; Strontium; Strontium Radioisotopes | 2001 |
186Re-1,4,8,11-tetraaza cyclotetradecyl-1,4,8,11-tetramethylene phosphonic acid: a novel agent for possible use in metastatic bone-pain palliation.
Topics: Analgesics; Animals; Bone Neoplasms; Etidronic Acid; Heterocyclic Compounds, 1-Ring; Injections, Intravenous; Male; Organometallic Compounds; Organophosphonates; Pain; Rabbits; Rats; Rats, Sprague-Dawley; Rhenium; Tissue Distribution | 2001 |
Rhenium-188 HEDP to treat painful bone metastases.
Topics: Bone Neoplasms; Etidronic Acid; Female; Follow-Up Studies; Humans; Leukocyte Count; Male; Middle Aged; Organometallic Compounds; Pain; Pain Management; Palliative Care; Platelet Count; Radionuclide Imaging; Radiopharmaceuticals; Rhenium | 2001 |